It is reported that a 52‐year‐old man diagnosed with stage IV non‐small cell lung cancer (NSCLC), was detected to overexpress HER‐2 and harbour an L869R mutation. This evidence concerns the gene ERBB2 and non-small cell lung carcinoma.